CervoMed
CRVO
22 hedge funds and large institutions have $9.11M invested in CervoMed in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 8 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
131% more capital invested
Capital invested by funds: $3.94M → $9.11M (+$5.17M)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
5% more funds holding
Funds holding: 21 → 22 (+1)
0.03% more ownership
Funds ownership: 0.1% → 0.13% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.17M |
| 2 |
BlackRock
New York
|
+$1.36M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$497K |
| 4 |
Millennium Management
New York
|
+$374K |
| 5 |
VF
Virtu Financial
New York
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.13M |
| 2 |
Two Sigma Investments
New York
|
-$85K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$63K |
| 4 |
Two Sigma Advisers
New York
|
-$23.5K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$17K | -277 | Closed |
|
27
Squarepoint
New York
| – | -$14K | -240 | Closed |
|
|
SWM
28
Sugarloaf Wealth Management
Duluth,
Georgia
| – | -$13K | -210 | Closed |
|
|
SEP
29
Southland Equity Partners
Wildwood,
Missouri
| – | -$9.56K | -160 | Closed |
|
|
VFA
30
Valeo Financial Advisors
Carmel,
Indiana
| – | -$1K | -13 | Closed |
|
CRVO Hedge Fund Activity: Q1 2021 in Review
22 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2021, worth a combined $9.11M — up 131% from $3.94M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CRVO positions and 8 closed out — a net gain of 1 holder — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $4.17M. The largest seller was Renaissance Technologies, cutting an estimated $1.13M.
- 22 institutional investors held CervoMed (CRVO) as of Q1 2021, up from 21 in Q4 2020.
- Funds reported $9.11M of CervoMed stock for Q1 2021, up 131% quarter-over-quarter.
- 9 funds opened new CervoMed positions in Q1 2021 and 8 closed out, a net change of +1 holder.
- The largest CervoMed buyer in Q1 2021 was Vanguard Group, an estimated $4.17M added.
- The largest CervoMed seller in Q1 2021 was Renaissance Technologies, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2021.